darunavir/cobicistat/emtricitabine/tenofovir alafenamide

darunavir/cobicistat/emtricitabine/tenofovir alafenamide is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Genetic Implications: Genetic Implications

Pronunciation:
da-roo-na-veer/koe-bik-i-stat/em-tri-si-ti-been/te-noe-fo-veer al-a-fen-a-mide

Trade Name(s)

  • Symtuza

Ther. Class.
antiretrovirals
pharmacoenhancers

Pharm. Class.
protease inhibitors
enzyme inhibitors
nucleoside reverse transcriptase inhibitors

-- To view the remaining sections of this topic, please or --

General

Genetic Implications: Genetic Implications

Pronunciation:
da-roo-na-veer/koe-bik-i-stat/em-tri-si-ti-been/te-noe-fo-veer al-a-fen-a-mide

Trade Name(s)

  • Symtuza

Ther. Class.
antiretrovirals
pharmacoenhancers

Pharm. Class.
protease inhibitors
enzyme inhibitors
nucleoside reverse transcriptase inhibitors

There's more to see -- the rest of this entry is available only to subscribers.